A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate the Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ROOTS
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2012 Planned number of patients changed from 227 to 330 as reported by ClinicalTrials.gov.